These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3412313)

  • 1. [Comparative study between carcinoembryonic antigen (CEA) in breast cancer tissue and histologic findings].
    Asagoe T; Yamoto H; Nemoto A; Kurosawa T; Shikata J; Aoki A; Nakayama R
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):789. PubMed ID: 3412313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CEA (carcinoembryonic antigen) in nipple discharge].
    Yagihashi A; Watanabe N
    Nihon Rinsho; 1999 Dec; 57 Suppl():450-1. PubMed ID: 10778161
    [No Abstract]   [Full Text] [Related]  

  • 4. The biological and clinical significance of tumor markers in tissue extracts.
    Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
    Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructural study of carcinoembryonic antigen (CEA) using the peroxidase-antiperoxidase (PAP) complex technic in patients with breast cancer].
    Grzanka A; Domaniewski J
    Patol Pol; 1989; 40(3):325-33. PubMed ID: 2701332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study between carcinoembryonic antigen (CEA) in breast cancer tissue and morphological regional immunoreaction: preliminary report].
    Asagoe T; Yamoto H; Hanatani Y; Horie H; Nemoto A; Kidooka K; Shikata J
    Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):534. PubMed ID: 2198457
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
    Eskelinen M; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(1):91-5. PubMed ID: 1567186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical detection of recurrent breast cancer.
    Smith RE
    Cancer Detect Prev; 1988; 11(3-6):303-9. PubMed ID: 3292045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor marker: practical usage of tumor marker for recurrent breast cancer--our experience].
    Yoshimoto M
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2277-83. PubMed ID: 2241194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA positivity in tissue and sera of patients with benign breast lesions.
    Wittekind C; Von Kleist S; Sandritter W
    Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomorphologic markers in breast cancer].
    Volchenko NN; Litvinova LV; Pugachev KK; Shimbireva IB; Kalashnikov VV; Frank GA
    Arkh Patol; 1996; 58(1):6-10. PubMed ID: 8929144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control.
    Staab HJ; Ahlemann LM; Anderer FA; Zwirner M; Schindler AE
    Cancer Detect Prev; 1985; 8(1-2):35-45. PubMed ID: 4064050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can treatment response be measured in breast cancer patients?
    van Dalen A; van der Linde DL; Heering KJ; van Oudalblas AB
    Anticancer Res; 1993; 13(5C):1901-4. PubMed ID: 8267398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
    Molina R; Filella X; Zanon G; Pahisa J; Alicarte J; Munoz M; Farrus B; Ballesta AM
    Anticancer Res; 2003; 23(2A):1043-50. PubMed ID: 12820345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CEA in nipple discharge].
    Yagihashi A
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():635-6. PubMed ID: 16149598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunohistochemical expression of the carcinoembryonic antigen in gallbladder cancer].
    Roa I; Araya JC; Wistuba I; De Aretxabala X; Salinas C; Mauriz A; Villaseca M
    Rev Med Chil; 1991 Feb; 119(2):129-36. PubMed ID: 1824154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoperoxidase staining for tumor markers in patients with carcinoma of the breast.
    Cox CE; Haagensen DE; Dilley WG; Wells SA
    Surg Forum; 1978; 29():160-2. PubMed ID: 401405
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R; Caffier H
    Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity and specificity of CEA, Ca 15-3 and MCA levels in visceral breast carcinoma metastasis].
    Delbrück H; Hagen-Aukamp C; Braun G
    Strahlenther Onkol; 1990 Jul; 166(7):457-9. PubMed ID: 2200152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
    Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
    Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.